Geneoscopy, Inc.

Geneoscopy, Inc.

Cancer Prevention | Diagnostics | Precision Medicine

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at Geneoscopy, Inc.. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
76 people
Headquarters
St. Louis, MO
Founded
2015
Type
Privately Held
Total funding
$217.9M

Geneoscopy Inc. is a life sciences company focused on developing diagnostic tests for gastrointestinal health. Leveraging its proprietary, patented stool-derived eukaryotic RNA (seRNA) biomarker platform, Geneoscopy’s mission is to empower patients and providers to transform gastrointestinal health through innovative diagnostics. The company’s FDA-approved ColoSense™ test uses a proprietary RNA-based platform to screen for colorectal cancer and advanced adenomas for average-risk individuals over the age of 45. In partnership with leading universities and biopharmaceutical companies, Geneoscopy is also developing diagnostic tests for treatment selection and therapy monitoring in other GI disease areas. For more information, visit www.geneoscopy.com and follow the company on LinkedIn.

Life Sciences Noninvasive Diagnostic Screening Colorectal Cancer Screening GI Health GI Disease Companion Diagnostics seRNA RNA Biomarkers Precision Medicine Partnerships and IBD

Open roles at Geneoscopy, Inc.